The DOI matches its Crossref record; 51 of the 52 references it cites were found in a registry or an index.
A polygenic burden of rare disruptive mutations in schizophrenia
Open accessAbstract
Schizophrenia is a common disease with a complex aetiology, probably involving multiple and heterogeneous genetic factors. Here, by analysing the exome sequences of 2,536 schizophrenia cases and 2,543 controls, we demonstrate a polygenic burden primarily arising from rare (less than 1 in 10,000), disruptive mutations distributed across many genes. Particularly enriched gene sets include the voltage-gated calcium ion channel and the signalling complex formed by the activity-regulated cytoskeleton-associated scaffold protein (ARC) of the postsynaptic density, sets previously implicated by genome-wide association and copy-number variation studies. Similar to reports in autism, targets of the fragile X mental retardation protein (FMRP, product of FMR1) are enriched for case mutations. No individual gene-based test achieves significance after correction for multiple testing and we do not detect any alleles of moderately low frequency (approximately 0.5 to 1 per cent) and moderately large effect. Taken together, these data suggest that population-based exome sequencing can discover risk alleles and complements established gene-mapping paradigms in neuropsychiatric disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These findings support our model in which CYFIP1 regulation of calcium channel subunits compromise intracellular calcium levels, resulting in delayed axonal development10,84,85 (Fig. 7).”
From CYFIP1 governs the development of cortical axons by modulating calcium availability (2025) · cites this paper as [10]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Additionally, a polygenic pattern including a rare heterozygous disruptive nonsense variant, p.Arg624Ter, in CYFIP1 was detected in a patient diagnosed with SCZ115 (Table 2n).”
From The WAVE complex in developmental and adulthood brain disorders (2025) · cites this paper as [115]
Experimental — accuracy not yet measuredIn the citing paper
“direct comparisons of the contributions of common and rare genetic variation show that common variation dominates heritable risk for SCZ and ASD (Gaugler et al., 2014; Purcell et al., 2014)”
From Defining the genetic, genomic, cellular, and diagnostic architectures of psychiatric disorders (2019) · cites this paper as Purcell et al., 2014
In the citing paper
“In the instances where this has been studied directly, polygenic risk acts additively with major mutational burdens (Gaugler et al., 2014; Niemi et al., 2018; Purcell et al., 2014; Weiner et al., 2017).”
From Defining the genetic, genomic, cellular, and diagnostic architectures of psychiatric disorders (2019) · cites this paper as Purcell et al., 2014
In the citing paper
“Thus, many severe mutations do not converge on one specific phenotype but instead seem to cause a range of clinical disorders74,76,80,81,84,87,91.”
From Systems biology and gene networks in neurodevelopmental and neurodegenerative disorders (2015) · cites this paper as [81]
In the citing paper
“Additionally, whole-exome sequencing studies of other neurodevelopmental disorders have found enrichment for FMRP targets in rare mutations in schizophrenia81, intellectual disability68 and epilepsy78.”
From Systems biology and gene networks in neurodevelopmental and neurodegenerative disorders (2015) · cites this paper as [81]
In the citing paper
“Earlier schizophrenia sequencing studies have established that ultra-rare and de novo mutations contribute to risk as a category, and have prioritized disease-relevant tissues and processes, specifically observing an enrichment in neuronal genes and synaptic processes9,11,19–23.”
From Rare coding variants in ten genes confer substantial risk for schizophrenia (2022) · cites this paper as [19]
In the citing paper
“among 5,092 (of the 12,332) individuals who were also part of an earlier sequencing study9, the additional data allowed us to re-classify ~66% of variants that had been “singletons” as segregating variants (not URVs in the current analysis).”
From Increased burden of ultra-rare protein-altering variants among 4,877 individuals with schizophrenia (2016) · cites this paper as [9]
In the citing paper
“A strong and consistent finding in exome-sequencing studies of schizophrenia involves an excess of variants in genes whose mRNAs are bound by the fragile X mental retardation protein (FMRP)9,12,27.”
From Increased burden of ultra-rare protein-altering variants among 4,877 individuals with schizophrenia (2016) · cites this paper as [9]
In the citing paper
“The observed enrichment was consistent across data from previously analyzed exomes9 and newly generated data (Supplementary Fig. 5); as the previously analyzed exomes were sequenced across randomized batches with equal number of cases and controls in each batch, this provides additional evidence that the enrichment is not due to technical effects.”
From Increased burden of ultra-rare protein-altering variants among 4,877 individuals with schizophrenia (2016) · cites this paper as [9]
In the citing paper
“The fact that an analysis of the current scale (4,877 cases, 6,203 controls, and 45,376 other genomes used to help identify ultra-rare variants) did not implicate individual genes of large effect in an unbiased exome-wide search – while documenting a very clear exome-wide elevation of hundreds of pathogenic variants across 4,877 individuals affected with schizophrenia relative to controls – lends”
From Increased burden of ultra-rare protein-altering variants among 4,877 individuals with schizophrenia (2016) · cites this paper as [9]
In the citing paper
“Psychiatric cases with a diagnosis of schizophrenia or bipolar disorder were ascertained from the Swedish National Hospital Discharge Register as described in previous studies9,50, which captures all inpatient hospitalizations. Controls were randomly selected from population registers.”
From Increased burden of ultra-rare protein-altering variants among 4,877 individuals with schizophrenia (2016) · cites this paper as [9]
In the citing paper
“SCZ is truly complex and appears to result from a myriad of genetic variants exerting small effects on disease risk4,5, conforming closely to a classical polygenic model.”
From Gene expression elucidates functional impact of polygenic risk for schizophrenia (2016) · cites this paper as [5]
In the citing paper
“SCZ is truly complex and appears to result from a myriad of genetic variants exerting small effects on disease risk4,5, conforming closely to a classical polygenic model.”
From Gene expression elucidates functional impact of polygenic risk for schizophrenia (2016) · cites this paper as [5]
In the citing paper
“The available data are incomplete but implicate synaptic components, including calcium channel subunits and post-synaptic elements5–7.”
From Gene expression elucidates functional impact of polygenic risk for schizophrenia (2016) · cites this paper as [5]
In the citing paper
“We note that strong, independent support of our findings comes from the observation that analyses of rare variants have also implicated postsynaptic pathways in SCZ etiology23,24, suggesting that both rare and common variants are relevant.”
From Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways (2015) · cites this paper as [24]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
A framework for variation discovery and genotyping using next-generation DNA sequencing data
DePristo, M. A., Banks, E., Poplin, R. E., Garimella, K. V., Maguire, J., Hartl, C., Philippakis, A., del Angel, G., Rivas, M. A., Hanna, M., et al. (2011) · Nature Genetics · doi:10.1038/ng.806 · Cited by 11,457
Self-citationCommon polygenic variation contributes to risk of schizophrenia and bipolar disorder
The International Schizophrenia Consortium (2009) · Nature · doi:10.1038/nature08185 · Cited by 4,821
Self-citation(2013) · The Lancet · doi:10.1016/s0140-6736(12)62129-1 · Cited by 3,010
Rare-Variant Association Testing for Sequencing Data with the Sequence Kernel Association Test
Wu, M. C., Lee, S., Cai, T., Li, Y., Boehnke, M., & Lin, X. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.05.029 · Cited by 2,373
Schizophrenia as a Complex Trait: Evidence From a Meta-analysis of Twin Studies
Sullivan, P. F., Kendler, K. S., & Neale, M. C. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.12.1187 · Cited by 2,356
Self-citationSporadic autism exomes reveal a highly interconnected protein network of de novo mutations
O’Roak, B. J., Vives, L., Girirajan, S., Karakoc, E., Krumm, N., Coe, B. P., Levy, R., Ko, A., Lee, C., Smith, J. D., et al. (2012) · Nature · doi:10.1038/nature10989 · Cited by 2,165
Lichtenstein, P., Yip, B. H., Björk, C., Pawitan, Y., Cannon, T. D., Sullivan, P. F., & Hultman, C. M. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60072-6 · Cited by 2,125
Self-citationDe novo mutations revealed by whole-exome sequencing are strongly associated with autism
Sanders, S. J., Murtha, M. T., Gupta, A. R., Murdoch, J. D., Raubeson, M. J., Willsey, A. J., Ercan-Sencicek, A. G., DiLullo, N. M., Parikshak, N. N., Stein, J. L., et al. (2012) · Nature · doi:10.1038/nature10945 · Cited by 2,084
FMRP Stalls Ribosomal Translocation on mRNAs Linked to Synaptic Function and Autism
Darnell, J. C., Van Driesche, S. J., Zhang, C., Hung, K. Y. S., Mele, A., Fraser, C. E., Stone, E. F., Chen, C., Fak, J. J., Chi, S. W., et al. (2011) · Cell · doi:10.1016/j.cell.2011.06.013 · Cited by 2,072
Cited by
Sorted by citations
Items 201–300 of 1,003
Lam, M., Hill, W. D., Trampush, J. W., Yu, J., Knowles, E., Davies, G., Stahl, E. A., Huckins, L. M., Liewald, D. C. M., Djurovic, S., et al. (2019) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2019.06.012 · Cited by 115
Self-citationSpatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders
Li, J., Zhang, W., Yang, H., Howrigan, D. P., Wilkinson, B., Souaiaia, T., Evgrafov, O. V., Genovese, G., Clementel, V. A., Tudor, J. C., et al. (2017) · Nature Neuroscience · doi:10.1038/nn.4594 · Cited by 114
Self-citationThe genetics of neuropsychiatric disorders
Bray, N. J., & O’Donovan, M. C. (2018) · Brain and Neuroscience Advances · doi:10.1177/2398212818799271 · Cited by 113
Synaptic UNC13A protein variant causes increased neurotransmission and dyskinetic movement disorder
Lipstein, N., Verhoeven‐Duif, N. M., Michelassi, F. E., Calloway, N. T., van Hasselt, P. M., Pienkowska, K., van Haaften, G. W., van Haelst, M. M., Empelen, R. V., Cuppen, I., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci90259 · Cited by 113
Song, J. H. T., Lowe, C. B., & Kingsley, D. M. (2018) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2018.07.011 · Cited by 112
A brain atlas of synapse protein lifetime across the mouse lifespan
Bulovaite, E., Qiu, Z., Kratschke, M., Zgraj, A., Fricker, D. G., Tuck, E. J., Gokhale, R., Koniaris, B., Jami, S. A., Merino-Serrais, P., et al. (2022) · Neuron · doi:10.1016/j.neuron.2022.09.009 · Cited by 111
Self-citationCYFIP family proteins between autism and intellectual disability: links with Fragile X syndrome
Abekhoukh, S., & Bardoni, B. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00081 · Cited by 110
Mahajan, A., Sim, X., Ng, H. J., Manning, A. K., Rivas, M. A., Highland, H. M., Locke, A. E., Grarup, N., Im, H. K., Cingolani, P., et al. (2015) · PLoS Genetics · doi:10.1371/journal.pgen.1004876 · Cited by 110
Self-citationShelton, M. A., Newman, J. T., Gu, H., Sampson, A. R., Fish, K. N., MacDonald, M. L., Moyer, C. E., DiBitetto, J. V., Dorph‐Petersen, K., Penzes, P., et al. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.12.029 · Cited by 109
Exome Sequencing of Familial Bipolar Disorder
Goes, F. S., Pirooznia, M., Parla, J. S., Kramer, M., Ghiban, E., Mavruk, S., Chen, Y.-C., Monson, E. T., Willour, V. L., Karchin, R., et al. (2016) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2016.0251 · Cited by 108
Self-citationClassics in Chemical Neuroscience: Ketamine
Tyler, M. W., Yourish, H. B., Ionescu, D. F., & Haggarty, S. J. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00074 · Cited by 108
Self-citationDefects in Bioenergetic Coupling in Schizophrenia
Sullivan, C. R., O'Donovan, S. M., McCullumsmith, R. E., & Ramsey, A. J. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.10.014 · Cited by 108
Duan, J., Shi, J., Fiorentino, A., Leites, C., Chen, X., Moy, W., Chen, J., Alexandrov, B. S., Usheva, A., S, D. H. B., et al. (2014) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2014.11.001 · Cited by 107
Self-citationCell type-specific epigenetic links to schizophrenia risk in the brain
Mendizabal, I., Berto, S., Usui, N., Toriumi, K., Chatterjee, P., Douglas, C., Huh, I., Jeong, H., Layman, T. S., Tamminga, C. A., et al. (2019) · Genome biology · doi:10.1186/s13059-019-1747-7 · Cited by 107
Munawar, N., Ahsan, K., Muhammad, K., Ahmad, A., Anwar, M. A., Shah, I., Ameri, A. A., & Mughairbi, F. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147671 · Cited by 107
Chen, C., Meng, Q., Xia, Y., Ding, C., Wang, L., Dai, R., Cheng, L., Gunaratne, P. H., Gibbs, R. A., Min, S., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aat8178 · Cited by 106
Viana, J., Hannon, E., Dempster, E., Pidsley, R., Macdonald, R., Knox, O., Spiers, H., Troakes, C., Al-Saraj, S., Turecki, G., et al. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw373 · Cited by 105
Analyzing the Role of MicroRNAs in Schizophrenia in the Context of Common Genetic Risk Variants
Hauberg, M. E., Roussos, P., Grove, J., Børglum, A. D., & Mattheisen, M. (2016) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.3018 · Cited by 105
Self-citationHomann, O. R., Misura, K. M. S., Lamas, E., Sandrock, R. W., Nelson, P., McDonough, S. I., & DeLisi, L. E. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.24 · Cited by 105
Rare Genome-Wide Copy Number Variation and Expression of Schizophrenia in 22q11.2 Deletion Syndrome
Bassett, A. S., Lowther, C., Merico, D., Costain, G., Chow, E. W. C., van Amelsvoort, T., McDonald‐McGinn, D. M., Gur, R. E., Swillen, A., van den Bree, M. B. M., et al. (2017) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2017.16121417 · Cited by 103
How important are rare variants in common disease?
Pierre, A. S., & Génin, E. (2014) · Briefings in Functional Genomics · doi:10.1093/bfgp/elu025 · Cited by 103
Justice, A. E., Karaderi, T., Highland, H. M., Young, K. L., Graff, M., Lu, Y., Turcot, V., Auer, P. L., Fine, R. S., Guo, X., et al. (2019) · Nature Genetics · doi:10.1038/s41588-018-0334-2 · Cited by 101
Identification and functional characterization of rare SHANK2 variants in schizophrenia
Peykov, S. Z., Berkel, S., Schoen, M., Weiss, K., Degenhardt, F., Strohmaier, J., Weiss, B., Proepper, C., Schratt, G. M., Nöthen, M. M., et al. (2015) · Molecular Psychiatry · doi:10.1038/mp.2014.172 · Cited by 100
IRSp53/BAIAP2 in dendritic spine development, NMDA receptor regulation, and psychiatric disorders
Kang, J., Park, H., & Kim, E. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.06.019 · Cited by 100
Genetic insights and neurobiological implications from NRXN1 in neuropsychiatric disorders
Hu, Z., Xiao, X., Zhang, Z., & Li, M. (2019) · Molecular Psychiatry · doi:10.1038/s41380-019-0438-9 · Cited by 99
Smeland, O. B., Shadrin, A. A., Bahrami, S., Broce, I., Tesli, M., Frei, O., Wirgenes, K. V., O’Connell, K. S., Krull, F., Bettella, F., et al. (2020) · Biological Psychiatry · doi:10.1016/j.biopsych.2020.01.026 · Cited by 98
Evidence of Mitochondrial Dysfunction within the Complex Genetic Etiology of Schizophrenia
Hjelm, B. E., Rollins, B. L., Mamdani, F., Lauterborn, J. C., Kirov, G., LYNCH, G. S., Gall, C. M., Sequeira, A., & Vawter, M. P. (2015) · Complex Psychiatry · doi:10.1159/000441252 · Cited by 98
Identification of genetic loci shared between schizophrenia and the Big Five personality traits
Smeland, O. B., Wang, Y., Lo, M., Li, W., Frei, O., Witoelar, A., Tesli, M., Hinds, D. A., Tung, J. Y., Djurovic, S., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-02346-3 · Cited by 97
Domínguez-Iturza, N., Lo, A. C., Shah, D., Armendáriz, M., Vannelli, A., Mercaldo, V., Trusel, M., Li, K. W., Gastaldo, D., Santos, A. R., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11203-y · Cited by 96
The Genetic Architecture of Major Depressive Disorder in Han Chinese Women
Peterson, R. E., Cai, N., Bigdeli, T. B., Li, Y., Reimers, M., Nikulova, A., Webb, B. T., Bacanu, S., Riley, B. P., Flint, J., et al. (2016) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2016.3578 · Cited by 97
Molecular substrates of schizophrenia: homeostatic signaling to connectivity
Landek‐Salgado, M. A., Faust, T. E., & Sawa, A. (2015) · Molecular Psychiatry · doi:10.1038/mp.2015.141 · Cited by 95
Schizophrenia genetics: emerging themes for a complex disorder
Kavanagh, D. H., Tansey, K. E., O’Donovan, M. C., & Owen, M. J. (2014) · Molecular Psychiatry · doi:10.1038/mp.2014.148 · Cited by 93
Emerging roles for MEF2 in brain development and mental disorders
Assali, A., Harrington, A. J., & Cowan, C. W. (2019) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2019.04.008 · Cited by 92
Motahari, Z., Moody, S. A., Maynard, T. M., & LaMantia, A. (2019) · Journal of Neurodevelopmental Disorders · doi:10.1186/s11689-019-9267-z · Cited by 92
Pershing, M. L., Bortz, D. M., Pocivavsek, A., Fredericks, P. J., Jørgensen, C. V., Vunck, S. A., Leuner, B., Schwarcz, R. M., & Bruno, J. P. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.10.017 · Cited by 92
Fernández, E., Collins, M. O., Frank, R., Zhu, F., Kopanitsa, M. V., Nithianantharajah, J., Lemprière, S. A., Fricker, D. G., Elsegood, K. A., McLaughlin, C. L., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.09.045 · Cited by 91
Self-citationGenetic evidence for role of integration of fast and slow neurotransmission in schizophrenia
Devor, A., Andreassen, O. A., Wang, Y., Mäki‐Marttunen, T., Smeland, O. B., Fan, C.-C., Schork, A. J., Holland, D., Thompson, W. K., Witoelar, A., et al. (2017) · Molecular Psychiatry · doi:10.1038/mp.2017.33 · Cited by 91
Santos, A. R., Kanellopoulos, A. K., & Bagni, C. (2014) · Learning & Memory · doi:10.1101/lm.035956.114 · Cited by 91
Methylomic changes during conversion to psychosis
the ICAAR team, Kébir, O., Chaumette, B., Rivollier, F., Miozzo, F., Perreault, L. L., Barhdadi, A., Provost, S., Plaze, M., Bourgin, J., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.53 · Cited by 90
Creson, T. K., Rojas, C., Hwaun, E., Vaissière, T., Kılınç, M., Jiménez-Gómez, A., Holder, J. L., Tang, J., Colgin, L. L., Miller, C. A., et al. (2019) · eLife · doi:10.7554/elife.46752 · Cited by 90
Schizophrenia Genomics: Convergence on Synaptic Development, Adult Synaptic Plasticity, or Both?
Hall, J., & Bray, N. J. (2021) · Biological Psychiatry · doi:10.1016/j.biopsych.2021.10.018 · Cited by 90
Kamijo, S., Ishii, Y., Horigane, S.-I., Suzuki, K., Ohkura, M., Nakai, J., Fujii, H., Takemoto-Kimura, S., & Bito, H. (2018) · The Journal of Neuroscience · doi:10.1523/jneurosci.2357-17.2018 · Cited by 89
Genome-scale neurogenetics: methodology and meaning
McCarroll, S. A., Feng, G., & Hyman, S. E. (2014) · Nature Neuroscience · doi:10.1038/nn.3716 · Cited by 89
Self-citationGanna, A., Genovese, G., Howrigan, D. P., Byrnes, A., Kurki, M., Zekavat, S. M., Whelan, C. W., Kals, M., Nivard, M. G., Bloemendal, A., et al. (2016) · Nature Neuroscience · doi:10.1038/nn.4404 · Cited by 89
Self-citationModeling psychiatric disorders: from genomic findings to cellular phenotypes
Falk, A., Heine, V. M., Harwood, A. J., Sullivan, P. F., Peitz, M., Brüstle, O., Shen, S., Sun, Y.-M., Glover, J. C., Posthuma, D., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.89 · Cited by 88
Self-citationRare variant MX1 alleles increase human susceptibility to zoonotic H7N9 influenza virus
Chen, Y., Graf, L., Chen, T., Liao, Q., Bai, T., Petric, P. P., Zhu, W., Yang, L., Dong, J., Lü, J., et al. (2021) · Science · doi:10.1126/science.abg5953 · Cited by 88
PSD-95: An Effective Target for Stroke Therapy Using Neuroprotective Peptides
Ugalde‐Triviño, L., & Díaz‐Guerra, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212585 · Cited by 89
Mitchell, A., Javidfar, B., Pothula, V., Ibi, D., Shen, E., Peter, C. J., Bicks, L. K., Fehr, T., Jiang, Y., Brennand, K., et al. (2017) · Molecular Psychiatry · doi:10.1038/mp.2016.254 · Cited by 88
The integrated landscape of causal genes and pathways in schizophrenia
Ma, C., Gu, C., Huo, Y., Li, X., & Luo, X. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0114-x · Cited by 87
Nguyen, H. T., Bryois, J., Kim, A., Dobbyn, A. L., Huckins, L. M., Muñoz‐Manchado, A. B., Ruderfer, D. M., Genovese, G., Fromer, M., Xu, X., et al. (2017) · Genome Medicine · doi:10.1186/s13073-017-0497-y · Cited by 87
Self-citationSpecies-conserved SYNGAP1 phenotypes associated with neurodevelopmental disorders
Kılınç, M., Creson, T. K., Rojas, C., Aceti, M., Ellegood, J., Vaissière, T., Lerch, J. P., & Rumbaugh, G. (2018) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2018.03.008 · Cited by 87
Transposable element-derived sequences in vertebrate development
Etchegaray, E., Naville, M., Volff, J., & Haftek-Terreau, Z. (2021) · Mobile DNA · doi:10.1186/s13100-020-00229-5 · Cited by 87
Dienel, S. J., Schoonover, K. E., & Lewis, D. A. (2022) · Biological Psychiatry · doi:10.1016/j.biopsych.2022.03.002 · Cited by 87
Fatemi, S. H., & Folsom, T. D. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.10.010 · Cited by 86
Genome-wide Polygenic Burden of Rare Deleterious Variants in Sudden Unexpected Death in Epilepsy
Leu, C., Balestrini, S., Maher, B. H., Hernández-Hernández, L., Gormley, P., Hämäläinen, E., Heggeli, K., Schoeler, N. E., Nový, J., Willis, J., et al. (2015) · EBioMedicine · doi:10.1016/j.ebiom.2015.07.005 · Cited by 85
Genetic Relationship between Schizophrenia and Nicotine Dependence
Chen, J., Bacanu, S., Yu, H., Zhao, Z., Jia, P., Kendler, K. S., Kranzler, H. R., Gelernter, J. E., Farrer, L. A., Minică, C. C., et al. (2016) · Scientific Reports · doi:10.1038/srep25671 · Cited by 85
Ishizuka, K., Fujita, Y., Kawabata, T., Kimura, H., Iwayama, Y., Inada, T., Okahisa, Y., Egawa, J., Usami, M., Kushima, I., et al. (2017) · Translational Psychiatry · doi:10.1038/tp.2017.173 · Cited by 87
Recent Advances in the Genetics of Schizophrenia
Avramopoulos, D. (2018) · Complex Psychiatry · doi:10.1159/000488679 · Cited by 84
Genome-wide association studies in schizophrenia: Recent advances, challenges and future perspective
Dennison, C. A., Legge, S. E., Pardiñas, A. F., & Walters, J. (2019) · Schizophrenia Research · doi:10.1016/j.schres.2019.10.048 · Cited by 84
Proteomic analysis of postsynaptic proteins in regions of the human neocortex
Roy, M. M., Sorokina, O., Skene, N., Simonnet, C., Mazzo, F., Zwart, R., Sher, E., Smith, C., Armstrong, J. D., & Grant, S. G. N. (2017) · Nature Neuroscience · doi:10.1038/s41593-017-0025-9 · Cited by 83
Self-citationA Burden of Rare Variants Associated with Extremes of Gene Expression in Human Peripheral Blood
Zhao, J., Akinsheye, I., Arafat, D., Cradick, T. J., Lee, C. M., Banskota, S., Marigorta, U. M., Bao, G., & Gibson, G. C. (2016) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2015.12.023 · Cited by 83
Halvorsen, M., Huh, R., Oskolkov, N., Wen, J., Netotea, S., Giusti‐Rodríguez, P., Karlsson, R., Bryois, J., Nystedt, B., Ameur, A., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15707-w · Cited by 83
Self-citationWang, Z.-J., Zhong, P., Ma, K., Seo, J.-S., Yang, F., Hu, Z., Zhang, F., Lin, L., Wang, J., Liu, T., et al. (2020) · Molecular Psychiatry · doi:10.1038/s41380-019-0351-2 · Cited by 82
Marenne, G., Hendricks, A. E., Perdikari, A., Bounds, R., Payne, F., Keogh, J. M., Lelliott, C. J., Henning, E., Pathan, S., Ashford, S. E., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.05.007 · Cited by 82
Animal models of gene–environment interaction in schizophrenia: A dimensional perspective
Ayhan, Y., McFarland, R., & Pletnikov, M. V. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.10.002 · Cited by 82
Suhl, J. A., Chopra, P., Anderson, B. R., Bassell, G. J., & Warren, S. T. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu272 · Cited by 81
Pak, C., Dankó, T., Mirabella, V. R., Wang, J., Liu, Y., Vangipuram, M., Grieder, S. D., Zhang, X., Ward, T., Huang, Y. A., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2025598118 · Cited by 84
Polygenic risk score and the psychosis continuum model
Tesli, M., Espeseth, T., Bettella, F., Mattingsdal, M., Aas, M., Melle, I. S., Djurovic, S., & Andreassen, O. A. (2014) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12307 · Cited by 81
Xie, W., Li, L., Zhang, M., Cheng, H., Gong, D., Lv, Y.-C., Yao, F., He, P., Ouyang, X.-P., Lan, G., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0157085 · Cited by 81
Zandi, P. P., Jaffe, A. E., Goes, F. S., Burke, E. E., Collado‐Torres, L., Huuki-Myers, L. A., Seyedian, A., Lin, Y., Seifuddin, F., Pirooznia, M., et al. (2022) · Nature Neuroscience · doi:10.1038/s41593-022-01024-6 · Cited by 82
Horowitz, J. E., Warner, N. E., Staples, J. C., Crowley, E., Gosalia, N., Murchie, R., Hout, C. V. V., Fiedler, K. B., Welch, G., King, A. K., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-84938-8 · Cited by 80
Greenwood, T. A., Lazzeroni, L. C., Calkins, M. E., Freedman, R., Green, M. F., Gur, R. E., Gur, R. C., Light, G. A., Nuechterlein, K. H., D, A. O. M., et al. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.11.008 · Cited by 79
Liu, D., Meyer, D., Fennessy, B., Feng, C., Cheng, E., Johnson, J., Park, Y. J., Rieder, M.-K., Ascolillo, S., de Pins, A. M., et al. (2023) · Nature Genetics · doi:10.1038/s41588-023-01305-1 · Cited by 78
Ranlund, S., Adams, R. A., Díez, Á., Constante, M., Dutt, A., Hall, M., Maestro Carbayo, A., McDonald, C., Petrella, S., Schulze, K., et al. (2016) · Human Brain Mapping · doi:10.1002/hbm.23035 · Cited by 77
Rees, E., O’Donovan, M. C., & Owen, M. J. (2014) · Current Opinion in Behavioral Sciences · doi:10.1016/j.cobeha.2014.07.001 · Cited by 77
Guan, F., Ni, T., Zhu, W., Williams, L. K., Cui, L., Li, M., Tubbs, J. D., Sham, P. C., & Gui, H. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01201-2 · Cited by 79
Human microglia maturation is underpinned by specific gene regulatory networks
Han, C. Z., Li, R. Z., Hansen, E., Trescott, S., Fixsen, B. R., Nguyen, C. T., Mora, C. M., Spann, N. J., Bennett, H. R., Poirion, O., et al. (2023) · Immunity · doi:10.1016/j.immuni.2023.07.016 · Cited by 84
A missense variant in FGD6 confers increased risk of polypoidal choroidal vasculopathy
Huang, L., Zhang, H., Cheng, C., Wen, F., Tam, P. O. S., Zhao, P., Chen, H., Li, Z., Chen, L., Tai, Z., et al. (2016) · Nature Genetics · doi:10.1038/ng.3546 · Cited by 77
Grazioplene, R. G., Chavez, R. S., Rustichini, A., & DeYoung, C. G. (2016) · Journal of Abnormal Psychology · doi:10.1037/abn0000176 · Cited by 76
Alural, B., Genç, Ş., & Haggarty, S. J. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2016.03.010 · Cited by 76
Self-citationGenetics of schizophrenia: A consensus paper of the WFSBP Task Force on Genetics
Giegling, I., Hosák, L., Mößner, R., Serretti, A., Bellivier, F., Claes, S. J., Collier, D. A., Corrales, A., DeLisi, L. E., Gallo, C., et al. (2017) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2016.1268715 · Cited by 76
Expression-based drug screening of neural progenitor cells from individuals with schizophrenia
Readhead, B. P., Hartley, B. J., Eastwood, B. J., Collier, D. A., Evans, D. A. P., Farias, R., He, C., Hoffman, G. E., Sklar, P. B., Dudley, J. T., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06515-4 · Cited by 76
Self-citationNew insights on synaptic dysfunction in neuropsychiatric disorders
Caldeira, G. L., Peça, J., & Carvalho, A. L. (2019) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2019.01.004 · Cited by 76
Mentis, A.-F. A., Lee, D., & Roussos, P. (2024) · Molecular Psychiatry · doi:10.1038/s41380-023-02047-6 · Cited by 75
Self-citationCell biology and dynamics of Neuronal Na+/K+-ATPase in health and diseases
Shrivastava, A. N., Triller, A., & Melki, R. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.12.008 · Cited by 75
Fullard, J. F., Giambartolomei, C., Hauberg, M. E., Xu, K., Voloudakis, G., Shao, Z., Bare, C., Dudley, J. T., Mattheisen, M., Robakis, N. K. R. K., et al. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx103 · Cited by 75
Self-citationChen, S., Fragoza, R., Klei, L., Liu, Y., Wang, J., Roeder, K., Devlin, B., & Yu, H. (2018) · Nature Genetics · doi:10.1038/s41588-018-0130-z · Cited by 75
Missing heritability of common diseases and treatments outside the protein-coding exome
Sadée, W., Hartmann, K., Seweryn, M. T., Pietrzak, M., Handelman, S. K., & Rempała, G. A. (2014) · Human Genetics · doi:10.1007/s00439-014-1476-7 · Cited by 74
A rare schizophrenia risk variant of CACNA1I disrupts CaV3.3 channel activity
Andrade, A., Hope, J. M., Allen, A., Yorgan, V. A., Lipscombe, D., & Pan, J. Q. (2016) · Scientific Reports · doi:10.1038/srep34233 · Cited by 74
Rare Variant Analysis of Human and Rodent Obesity Genes in Individuals with Severe Childhood Obesity
Hendricks, A. E., Bochukova, E. G., Marenne, G., Keogh, J. M., Atanassova, N., Bounds, R., Wheeler, E., Mistry, V., Henning, E., Körner, A., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-03054-8 · Cited by 74
Tanigawa, Y., Li, J., Justesen, J. M., Horn, H., Aguirre, M., DeBoever, C., Chang, C. C., Narasimhan, B., Lage, K., Hastie, T. J., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11953-9 · Cited by 74
A meta-analysis of gene expression quantitative trait loci in brain
Kim, Y., Xia, K., Tao, R., Giusti-Rodriguez, P., Vladimirov, V, van den Oord, E., & Sullivan, P. F. (2014) · Translational Psychiatry · doi:10.1038/tp.2014.96 · Cited by 73
Self-citationObi-Nagata, K., Temma, Y., & Hayashi‐Takagi, A. (2019) · Proceedings of the Japan Academy Series B · doi:10.2183/pjab.95.014 · Cited by 72
Nakamura, T., & Takata, A. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02005-2 · Cited by 72
A genetic association study of CSMD1 and CSMD2 with cognitive function
Athanasiu, L., Giddaluru, S., Fernandes, C. P. D., Christoforou, A., Reinvang, I., Lundervold, A. J., Nilsson, L., Kauppi, K., Adolfsson, R., Eriksson, E., et al. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.11.026 · Cited by 72
van de Leemput, J., Hess, J., Glatt, S. J., & Tsuang, M. T. (2016) · Advances in genetics · doi:10.1016/bs.adgen.2016.08.001 · Cited by 71
Tamouza, R., Meyer, U., Foiselle, M., Richard, J., Wu, C., Boukouaci, W., Corvoisier, P. L., Barrau, C., Lucas, A., Perron, H., et al. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01499-0 · Cited by 71
Whole genome/exome sequencing in mood and psychotic disorders
Kato, T. (2014) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12247 · Cited by 71
Copy Number Variable MicroRNAs in Schizophrenia and Their Neurodevelopmental Gene Targets
Warnica, W. D., Merico, D., Costain, G., Alfred, S. E., Wei, J., Marshall, C. R., Scherer, S. W., & Bassett, A. S. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.05.011 · Cited by 71
de Vrij, F. M. S., Bouwkamp, C. G., Gunhanlar, N., Shpak, G., Lendemeijer, B., Baghdadi, M., Gopalakrishna, S., Ghazvini, M., Li, T. M. W. Y., Quadri, M., et al. (2018) · Molecular Psychiatry · doi:10.1038/s41380-017-0004-2 · Cited by 71
Metadata
- Authors
- Purcell, S. M., Moran, J. L., Fromer, M., Ruderfer, D., Solovieff, N., Roussos, P., O’Dushlaine, C., Chambert, K., Bergen, S. E., Kähler, A., Duncan, L., Stahl, E., Genovese, G., Fernández, E., Collins, M. O., Komiyama, N. H., Choudhary, J. S., Magnusson, P. K. E., Banks, E., Shakir, K., Garimella, K., Fennell, T., DePristo, M., Grant, S. G. N., Haggarty, S. J., Gabriel, S., Scolnick, E. M., Lander, E. S., Hultman, C. M., Sullivan, P. F., McCarroll, S. A., & Sklar, P.
- Affiliations
- Broad Institute (US)
- Icahn School of Medicine at Mount Sinai (US)
- Massachusetts General Hospital (US)
- Karolinska Institutet (SE)
- KU Leuven (BE)
- Wellcome Sanger Institute (GB)
- University of Edinburgh (GB)
- University of North Carolina at Chapel Hill (US)
- Corresponding author
- Purcell, Shaun M.
- ORCID
- Purcell, Shaun M.
- Moran, Jennifer L.
- Fromer, Menachem
- Ruderfer, Douglas
- Solovieff, Nadia
- Roussos, Panos
- Bergen, Sarah E.
- Kähler, Anna
- Duncan, Laramie
- Genovese, Giulio
- Fernández, Esperanza
- Collins, Mark O.
- Komiyama, Noboru H.
- Choudhary, Jyoti S.
- Magnusson, Patrik K. E.
- Banks, Eric
- Garimella, Kiran
- Fennell, Tim
- Grant, Seth G. N.
- Haggarty, Stephen J.
- Gabriel, Stacey
- Scolnick, Edward M.
- Lander, Eric S.
- Sullivan, Patrick F.
- McCarroll, Steven A.
- Sklar, Pamela
- Venue
- Nature
- Published
- 2014-01-22
- Volume
- 506
- Issue
- 7487
- Pages
- 185-190
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4136494
- OpenAlex
- W2132297623
- Cited by
- 1,385
- References
- 52
- Citations by year
- 2026: 23 · 2025: 39 · 2024: 34 · 2023: 60 · 2022: 96 · 2021: 98 · 2020: 123 · 2019: 145 · 2018: 158 · 2017: 169 · 2016: 169 · 2015: 158 · 2014: 113
- FWCI
- 154.88
- Type
- journal article
- Language
- en
- Open access
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- UNC Libraries
- Funders
- U.S. Department of Veterans Affairs (I01BX002395)
- Wellcome Trust
- European Commission (242167, 241995)
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek (645-000-003)
- Karolinska Institutet
- Vetenskapsrådet (R01 MH077139)
- National Institutes of Health (241995)
- Stanley Center for Psychiatric Research, Broad Institute
- Medical Research Council
- National Heart, Lung, and Blood Institute
- National Institute of Mental Health (R01MH077139, T32MH017119, TT32MH017119, R01MH095088, RC2MH089905, R01MH095034, MH077139, R01MH091115, R01MH099126)
- National Human Genome Research Institute (U54HG003067, R01HG005827)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Keywords
- schizophrenia, polygenic burden, exome sequencing, activity-regulated cytoskeleton-associated protein, postsynaptic density, FMRP, glutamatergic synapses, autism spectrum disorder
- MeSH terms
- Disks Large Homolog 4 Protein, Autistic Disorder, Cytoskeletal Proteins, Female, Humans, Male, Membrane Proteins, Intellectual Disability, Mutation, Nerve Tissue Proteins, Schizophrenia, Calcium Channels, Receptors, N-Methyl-D-Aspartate, Multifactorial Inheritance, Intracellular Signaling Peptides and Proteins, Fragile X Messenger Ribonucleoprotein 1, Genome-Wide Association Study, DNA Copy Number Variations
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
